Invasive Meningococcal outbreak toolbox
Updated | October 2024
Welcome to the Invasive Meningococcal Outbreak toolbox
Key reference documents
- Meningococcus: Surveillance standards for vaccine-preventable diseases (Geneva: World Health Organization; 2018).
- Meningococcal meningitis (Brazzaville: WHO Regional Office for Africa).
- Meningitis information page (Geneva: World Health Organization).
- Meningitis fact sheet (Geneva: World Health Organization; 2021).
Case definitions
WHO suggested invasive meningococcal outbreak case definition
Any individual with sudden-onset fever and any of the following:
• neck stiffness
• Brudzinski’s sign
• Kernig’s sign
• altered mental state or impaired consciousness
• photophobia
• focal neurological deficits
• new-onset seizures (in adults)
• bulging fontanelle (in infants)
• haemorrhagic skin rash
• hypotension or shock and signs of hypoperfusion
• severe headache
• gastrointestinal complaints (vomiting and/or diarrhoea)
• constitutional symptoms (arthralgia, myalgia, body and/or leg pain)
A suspected case with any of the following:
• Gram-negative diplococci identified from any normally sterile body fluid (e.g. CSF specimen or blood culture)
• antigen detection test positive for N. meningitidis from any normally sterile body fluid (e.g. CSF specimen or blood culture)
• CSF with a cloudy, turbid or purulent appearance
• CSF WBCs >1000/mm3
• CSF WBCs >100/mm3 and CSF–blood glucose ratio <0.4
• CSF WBCs >100/mm3 and CSF glucose <2.2 mmol/L or <40 mg/dL
• CSF WBCs >100/mm3 and CSF total protein >1 g/L or >100 mg/dL
- A suspected or probable case with a positive culture or molecular test (PCR) for N. meningitidis from any normally sterile body fluid (e.g. CSF or blood)
- Suspected case where laboratory test shows another pathogen.
WHO suggested invasive meningococcal disease (IMD) surveillance case definition
- .Any individual with a suspected clinical diagnosis of invasive meningococcal disease
A suspected case with any of the following:
• Gram-negative diplococci identified from any normally sterile body fluid (e.g. CSF specimen or blood culture)
• antigen detection test positive for N. meningitidis from any normally sterile body fluid (e.g. CSF specimen or blood culture)
- A suspected or probable case with a positive culture or molecular test (PCR) for N. meningitidis from any normally sterile body fluid (e.g., CSF or blood)
WHO other definition
Definition of a contact of a case
Close contacts should be defined based on context-specific considerations and available resources. In the presence of an index case, during the 7 days before symptom onset and until 24 hours after initiation of appropriate antibiotic therapy, people at increased risk of infection include:
- individuals with prolonged exposure while in close proximity (less than 1 metre) to the index case (e.g., household contacts);
- individuals directly exposed to oral secretions of the index case (e.g. via kissing, mouth-to-mouth resuscitation, endotracheal intubation).
1. A normally sterile fluid is defined as blood, cerebrospinal fluid, joint fluid or other sterile site.
Data collection tools
- Case investigation form: PDF | Word
- Line list:
- Annex 6: WHO generic line list for reporting from health facility to district (during outbreak) Standard operating procedures for surveillance of meningitis, preparedness and response to epidemics in Africa: Merged standard operating procedures (Geneva: World Health Organization; 2018) Page 48-49.
- Annex 7: Standardized excel data collection tool for enhanced surveillance of Meningitis Standard operating procedures for surveillance of meningitis, preparedness and response to epidemics in Africa: Merged standard operating procedures (Geneva: World Health Organization; 2018) Page 50.
- Electronic tools: Not available.
Laboratory confirmation
- Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual, 2nd ed (Geneva: World Health Organization; 2011).
- Meningococcus: Surveillance standards for vaccine-preventable diseases (Geneva: World Health Organization; 2018 (page 5-7)).
Response tools and resources
- Managing meningitis epidemics in Africa. A quick reference guide for health authorities and health care workers (Geneva: World Health Organization; 2015).
- Standard operating procedures for surveillance of meningitis, preparedness and response to epidemics in Africa: Merged standard operating procedures (Geneva: World Health Organization; 2018).
- WHO guidelines on meningitis diagnosis, treatment and care (April 2025).
Training
- Meningitis introduction (Geneva: World Health Organization).
Other resources
- Managing epidemics: key facts about major deadly diseases (Geneva: World Health Organization; 2018).
- Disease commodity packages - Meningococcal Meningitis (Geneva: World Health Organization; 2018).